By a GenomeWeb staff reporter

SAN FRANCISCO (GenomeWeb News) – Speaking at the JP Morgan Healthcare Conference here today, Life Technologies Chairman and CEO Greg Lucier provided further comments on the firm's launch of the Ion Proton Sequencer, a new instrument designed to sequence an entire human genome in a day for $1,000.

The new benchtop sequencer is priced at $149,000 and is the next generation of its Ion Personal Genome Machine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.